Demystifying neuroplasticity

35
06/15/2022 a connected health solution that helps people train body and brain together as ONE system Alakananda Banerjee Chairperson Dharma Foundation of India TM

Transcript of Demystifying neuroplasticity

Page 1: Demystifying neuroplasticity

05/01/2023

a connected health solution that helps people train body and brain together as ONE system

Alakananda BanerjeeChairperson

Dharma Foundation of India

TM

Page 2: Demystifying neuroplasticity

05/01/2023 2

The Disability Problem – Is it entirely clinical?

• The number of disabled people worldwide crossed 1 billion in 2012 (WHO Report, 2013)

• The mainstay of treatment is still manual therapy, which is difficult to scale up to meet the exploding demand

• Therapists do not have any technology in the ward which shows them what is happening “internally” at brain-muscle levels while patient is practicing tasks and activities.

• Chronic conditions such as stroke, hypertension, diabetes and brain injury all lead to mild or severe disability

TM

Page 3: Demystifying neuroplasticity

TM

How does “ability” affect biology?

• The brain has a fundamental capacity to remap itself based on conscious and unconscious responses

• Neurons that “fire” together will “wire” together (Hebb, 1949)

• Repeated patterns of use get imprinted into the neuro-muscular system

The difficult part is understanding which reactions need to be activated and inhibited in both the brain and muscle.

Page 4: Demystifying neuroplasticity

Neuroplasticity• CNS structural changes occur because of interaction

between both genetic and environmental factors

• 100 billion neurons constantly lay down new pathways for neural communication and to rearrange existing ones throughout life thereby aiding the processes of:-

LearningMemory and Adaptation through new experience

(Jacqui Ancliffe, Senior Physio, RPH, WSC)

TM

Page 5: Demystifying neuroplasticity

TM

Neuroplasticity leads to…..

• Memorizing a new fact• Mastering a new skill�• Adjusting in a new environment��• Recovery from brain injuries�• Overcome cognitive disabilities�

Page 6: Demystifying neuroplasticity

TM

Mechanisms of neural plasticity

• The organism interfacing with its environment(stimulus)• Experience “enters” the brain by way of afferent inputs

through the sensory modalities.• These signals are then relayed via established neural

networks to higher cortical areas where a chain of processes ensure proper disposition of these inputs.

Page 7: Demystifying neuroplasticity

TM

Concepts of neuroplasticity

1. Enhancement of existing connections

• Functional plasticity• Produces short term

functional changes• Eg:- learning a new

task

1. Formation of new connections

• Structural plasticity• Long term

modification of • Behaviour• Eg:-skilled actions

Page 8: Demystifying neuroplasticity

TM

Page 9: Demystifying neuroplasticity

TM

Page 10: Demystifying neuroplasticity

TM

Changes in biology and its effect on function

Brain led changes…..• Long term inappropriate use of brain and muscle results in

altered function at neuron and muscle fibre levels resulting in “plateaus”.

• It thus becomes a self-perpetuated disease.

Spike timing–dependent plasticity (STDP) (Corporale et al, 2008) Manipulations of sensory experience (Merzenich et al, 1998) Electrical activity plays crucial roles in the structural and functional refinement of neural circuits

(Gilbert, 1998, Katz & Shatz 1996)

Page 11: Demystifying neuroplasticity

TM

Changes in biology and its effect on function

Muscle led changes…..• Non-use of certain muscles results in tissue contraction,

excessive muscle tone(spasticity), low ROM, joint stiffness• Excessive use of other muscles as compensation results in

chronic pain and repetitive injury• Low functional use further reinforces maladaptation and brain

re-mapping

(Taub et al, 1993; Bach-y-Rita, 1990)

Page 12: Demystifying neuroplasticity

TM

How does “disability” affect biology?The dark side of neuroplasticity

• Injured or affected joints and muscles alter the “map” within the brain, diminishes co-ordination of muscles and joints, especially stabilizers. The result is a less-than-stable platform for the arms and legs to work from; the person then has to exert a greater muscular force to achieve the results .In turn leads to earlier fatigue, decreased performance, injuries or pain.

• Brain injury and trauma in turn may result in muscle disuse in various body parts, leading to atrophy, tissue contracture , spasticity, high tone and a progressive change in fibre type and quality.

Brain and Muscle affect each other biologically at every stage of progression of chronic conditions

Page 13: Demystifying neuroplasticity

Can we use Physio-Neuro Training to re-architecture biology via the

“function” route?

TM

Page 14: Demystifying neuroplasticity

TM

The synergistic neuroplasticity model

Augmented

Feedforward

Augmented

Feedback

Augmented Feedforward

- Audio-video led imagery

Augmented Feedback

- EEG balance feedback

- EMG balance feedback

Page 15: Demystifying neuroplasticity

TM

Stepping Stones to “Self-Correction”• Re- map the Brain using movement – disrupt existing

homeostasis• “Self-correct” muscle tone, synergy, hemispheric activation• Modify habitual muscle fibre / neuron response• Re-architecture brain-muscle responses by bringing hitherto

unconscious responses within conscious control• Reinforce repeatedly and gently till it is imprinted into biology

– achieve new homeostasis

Thus leveraging principles of neuroplasticity can affect biology at tissue and function levels

Page 16: Demystifying neuroplasticity

TM

Using wearable technology to accelerate re-structuring of

function and health

Solving the clinical and socio-economic problem as parts of

one comprehensive solution

Page 17: Demystifying neuroplasticity

TM

Long term functional deficits in Stroke/TBI/Chronic Neuro degeneartive case

• Patient do not respond to the standard physiotherapy

• Patient compliance to the home programmes.• Unavailability of physiotherapy facilities.• Unavailability of caregivers/inadequate or unsafe

transport facilities to accompany patient to rehabilitation.

Page 18: Demystifying neuroplasticity

What is SynPhNe?

A wearable, portable, connected device that trains the brain and body as ONE system – Accelerates recovery– Provides new insights to therapist– Reduces therapist time– Is affordable to own or rent– Is easier on the caregiver

TM

Page 19: Demystifying neuroplasticity

TM

How does SynPhNe work?

• Muscle activation and inhibition trained together, always tracking ratios

• Maps brain response in terms of symmetry, relaxation, alertness, inter-hemispheric inhibition

• Training of brain and muscle occurs in a time-locked, Hebbian manner through “self-correction”

• Use of feed forward along with real-time feedback

• Simple User Interface using cartoon characters aids process by reducing attention demands

Page 20: Demystifying neuroplasticity

Exercises, Tasks

Warm Ups – 20 min

5 reps each warm up

Task Practice – 20 min

5 - 10 reps each task

TM

Page 21: Demystifying neuroplasticity

Set UpTM

Page 22: Demystifying neuroplasticity

EEG Cap and EMG GloveTM

Page 23: Demystifying neuroplasticity

A randomized 20-subject clinical trial of the SynPhNe stroke rehabilitation

system on hemiplegic stroke patients to improve recovery of hand function after

stroke.Collaboration Study between Max Super Speciality Hospital,Saket, New

Delhi and Nanyang Technical University, Singapore

TM

Page 24: Demystifying neuroplasticity

Study Objectives

• Primary objectives– To compare clinical motor outcomes achieved using

Synphne system (treatment group) with standard clinical care delivered by therapist (control group)

– To study effect sizes in treatment group over a 18 session (6 week) treatment period

• Secondary objectives– To assess pain and discomfort levels before and after

therapy session in treatment group– To assess ease of use, enjoyment, usefullness of Synphne

system in treatment group

TM

Page 25: Demystifying neuroplasticity

Subject Demographics

• To establish applicability and feasibility in a wide subject base, no restrictions were placed on location, type of stroke, months post-stroke, gender or age.

• Subjects were allocated to treatment and control group alternatively on first-come basis as they were recruited/referred.

• Synphne system was installed in the therapy centre so that it was in same environment as standard care

TM

Page 26: Demystifying neuroplasticity

TM

Subject Demographics – Treatment

Subject Age GenderMonths/Days

post CVANature of

StrokeSide of Stroke

Affected limb

No

Location

MLH003 28 F 48 months Haemorrhage Right Left FirstHaemorrhage - Others MLH006 53 F 8 months Infarct Right Left FirstInfarct - Lacunar Stroke MLH008 76 F 10 months Infarct Left Left FirstInfarct - Lacunar Stroke MLH009 51 M 5 months Infarct Right Left FirstRt Bg And Rt Periventricural Infarct MLH014 67 M 7 days Infarct Right Left FirstHaemorrhage - Basal Ganglia / Thalamus/subcortical MRH005 29 M 53 months Haemorrhage Left Right FirstHaemorrhage - Others MRH013 30 F 18 months Infarct Left Right FirstLeft Mca Territory In Fronto-Partietal MRH015 75 M 22 months Infarct Left Right FirstLt Mca Infarct With Ganglinoc Capsular MRH016 60 M 1 month Haemorrhage Left Right FirstBasal Ganglia / Thalamus/subcorticalMRH017 30 M 12 months Infarct Left Right FirstPartial Anterior Circulation StrokeMRH019 58 M 20 months Haemorrhage Left Right FirstInfarct - Lacunar StrokeMRH020 66 M 15 days Infarct Left Right FirstInfarct - Partial Anterior Circulation StrokeMLH021 60 M 3 months Infarct Right Left FirstInfarct - Total Anterior Circulation StrokeMRH022 74 M 35 days Haemorrhage Left Right FirstHaemorrhage - Basal Ganglia / Thalamus/subcorticalMLH023 43 M 16 months Infarct Right Left FirstInfarct - Partial Anterior Circulation Stroke

Page 27: Demystifying neuroplasticity

Subject Demographics - ControlSubject Age Gender

Months/Days post CVA

Nature of Stroke

Side of Stroke

Affected limb

No

Location

MCG002 63 M4 days

Left Right FirstMRI could not be done due to nailing in femur and left hand

MCG003 53 M 4 days Infarct Right Left FirstPartial Anterior Circulation Stroke MCG005 72 M 45 days Infarct Left Right FirstPosterior Circulation StrokeMCG006 65 M 3 days Infarct Left Right FirstBasal GangaliaMCG007 65 F 6 months Infarct Right Left RecurrentTotal Anterior Circulation StrokeMCG008 30 F 24 months Infarct Right Left FirstTotal Anterior Circulation StrokeMCG009 74 F 45 days Infarct Left Right FirstPartial Anterior Circulation StrokeMCG010 46 M 5 months Haemorrhage Left Right FirstBasal Ganglia / Thalamus/subcorticalMCG011 61 M 30 days Infarct Left Right FirstPartial Anterior Circulation Stroke

MCG012 67 M 20 months Both Left Right RecurrentFor Infarct:Partial Anterior Circulation StrokeFor Haemorrhage:Basal Ganglia / Thalamus/subcortical

MCG013 48 M 4 months Haemorrhage Left Right FirstBasal Ganglia / Thalamus/subcorticalMCG014 60 M 15 days Infarct Right Left FirstPartial Anterior Circulation StrokeMCG015 71 M 10 days Infarct Right Left FirstPartial Anterior Circulation StrokeMCG016 74 M 3 days Infarct Left Right FirstInfarct in Left Corona RadiataMCG017 41 M 15 days Infarct Left Right FirstPartial Anterior Circulation Stroke

TM

Page 28: Demystifying neuroplasticity

TM

Pre-Study Demographics ComparisonGroup Gender Age

(yrs)Post CVA (months)

FMA ARAT Grip strength

9 Hole Peg Test

Treatment 11 male 53 14.5 39.13 23.27 2.447 79.12

4 female 6 cannot attempt

Control 12 male 59 4.34 44.87 30.60 5.482 84.10

3 female 5 cannot attempt

• In general, the control group subjects were found to be a higher functioning group when compared to treatment group prior to start of study.

• The control group was also on average significantly early after stroke (average 4.34 months) as compared to treatment group (average 14.5 months).

Page 29: Demystifying neuroplasticity

Outcomes ComparisonX axis – Subjects 1-15Y axis - % improvement at Week 3 wrt Week 0 baseline assessment score

Although control group subjects started out as higher functioning individuals at Week 0 assessment, we find from the plot and two-tailed t-test that percentage improvements in both groups were not significantly different for FMA (Fugl-Meyer Assessment of Motor Recovery after Stroke) and ARAT (Action Research Arm Test) scales.

We used FMA to understand “gross movement” and ARAT to assess Activities of Daily Living; Coordination; Dexterity; Upper Extremity Function “

TM

Page 30: Demystifying neuroplasticity

Outcomes ComparisonX axis – Subjects 1-15Y axis - % improvement at Week 3 wrt Week 0 assessment score

We find from the two-tailed t-test that percentage improvements in both groups were significantly different for Grip Strength (although may be attributed to an outlier) and 9 Hole Peg Test scales (could be attributed to more chronic and severe subjects in treatment group).

We used Grip Strength Assessment to asses “strength” and 9 Hole Peg Test to assess “dexterity”.

TM

Page 31: Demystifying neuroplasticity

Outcomes based on International Classification of Functioning(ICF)

Mental

function of s

equen

cing c

omplex m

ovemen

ts

Seeing F

untions

Proprio

ceptive

function

Touch

function

sensory

of pain

Mobility o

f joint fu

nctions

Muscle p

ower functions

Muscle t

one functi

ons

Control o

f voluntar

y move

ment fu

nctions0

1020304050607080

Treatment GroupControl Group

Carryin

g out d

aily ro

utine

Lifting a

nd carry

ing objec

ts

Fine h

and use

Hand an

d arm us

Driving

Washing o

neself

Caring f

or body p

arts

Toileti

ng

Dressin

gEati

ng

Drinkin

g0

20

40

60

80

100

120

Treatment GroupControl Group

TM

Page 32: Demystifying neuroplasticity

ICF Outcomes

Mental

function of s

equen

cing c

omplex m

ovemen

ts

Seeing f

unctions

Proprio

ceptive

function

Touch

function

sensory

of pain

Mobility o

f joint fu

nctions

Muscle p

ower functions

Muscle t

one functi

ons

Control o

f voluntar

y move

ment fu

nctions0

1020304050607080

IMPROVEMENTS IN ICF CODES FOR “FUNCTION”

TM

Page 33: Demystifying neuroplasticity

ICF Outcomes

0

20

40

60

80

100

120

IMPROVEMENTS IN ICF CODES FOR “ACTIVITY”

TM

Page 34: Demystifying neuroplasticity

Patient satisfaction TM

Page 35: Demystifying neuroplasticity